SRH Advisors’s Bio-Techne TECH Stock Holding History

SRH Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.67K	Hold	52	–	–	﹤0.01%	256
2026 Q1	$2.72K	Hold	52	–	–	﹤0.01%	261
2025 Q4	$3.06K	Hold	52	–	–	﹤0.01%	266
2025 Q3	$2.89K	Hold	52	–	–	﹤0.01%	255
2025 Q2	$2.67K	Hold	52	–	–	﹤0.01%	251
2025 Q1	$3.05K	Hold	52	–	–	﹤0.01%	252
2024 Q4	$3.75K	Hold	52	–	–	﹤0.01%	256
2024 Q3	$4.16K	Hold	52	–	–	﹤0.01%	253
2024 Q2	$3.73K	Hold	52	–	–	﹤0.01%	266
2024 Q1	$3.66K	Hold	52	–	–	﹤0.01%	275
2023 Q4	$4.01K	Hold	52	–	–	﹤0.01%	266
2023 Q3	$3.54K	Hold	52	–	–	﹤0.01%	263
2023 Q2	$3.86K	Hold	52	–	–	﹤0.01%	255
2023 Q1	$4K	Hold	52	–	–	﹤0.01%	255
2022 Q4	$4K	Hold	52	–	–	﹤0.01%	259
2022 Q3	$4K	Hold	52	–	–	0.01%	272
2022 Q2	$5K	Hold	52	–	–	0.01%	257
2022 Q1	$6K	Hold	52	–	–	0.01%	254
2021 Q4	$7K	Hold	52	–	–	0.01%	249
2021 Q3	$6K	Buy	+52	New	+$6.33K	0.01%	250
2015 Q1	–	Sell	-52	Closed	-$1K	–	258
2014 Q4	$1K	Hold	52	–	–	0.01%	243
2014 Q3	$1K	Buy	+52	New	+$1.22K	0.01%	232

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SRH Advisors's TECH Position: Q2 2026 in Review

SRH Advisors held its Bio-Techne (TECH) position steady in Q2 2026 at 52 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

SRH Advisors first reported a position in TECH in Q3 2014 and has held it in 22 quarters since. The position peaked at $7K in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

SRH Advisors held 52 shares of Bio-Techne worth $3.67K as of Q2 2026.
SRH Advisors left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of SRH Advisors's portfolio in Q2 2026, its #256 holding.
SRH Advisors first reported a position in Bio-Techne in Q3 2014 and has held it in 22 quarters since.
SRH Advisors's Bio-Techne position peaked at $7K in Q4 2021.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on SRH Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.